{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:44:28Z","timestamp":1780393468037,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Funds for the innovation of science and Technology\uff0cFujian province","award":["2023Y9451"],"award-info":[{"award-number":["2023Y9451"]}]},{"name":"Joint Funds for the innovation of science and Technology\uff0cFujian province","award":["2023Y9449"],"award-info":[{"award-number":["2023Y9449"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J011273"],"award-info":[{"award-number":["2023J011273"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2024J011099"],"award-info":[{"award-number":["2024J011099"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fujian Cancer Hospital High-Level Talent Training Program","award":["2024YNG09"],"award-info":[{"award-number":["2024YNG09"]}]},{"DOI":"10.13039\/501100018534","name":"Fujian Provincial Medical Innovation Project","doi-asserted-by":"crossref","award":["2024CXA031"],"award-info":[{"award-number":["2024CXA031"]}],"id":[{"id":"10.13039\/501100018534","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00483-8","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T05:25:04Z","timestamp":1746249904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dynamic causal effects of gut microbiota on cervical Cancer lesion progression"],"prefix":"10.1038","volume":"15","author":[{"given":"Fei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"483_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.semcancer.2021.05.031","volume":"86","author":"A Khan","year":"2022","unstructured":"Khan, A. et al. Insights into the role of complement regulatory proteins in HPV mediated cervical carcinogenesis. Semin Cancer Biol. 86, 583\u2013589 (2022).","journal-title":"Semin Cancer Biol."},{"key":"483_CR2","doi-asserted-by":"crossref","unstructured":"Rahangdale, L., Mungo, C., O\u2019Connor, S. & Chibwesha, C. J. & Brewer, N. T. Human papillomavirus vaccination and cervical cancer risk. BMJ 379, e070115, (2022).","DOI":"10.1136\/bmj-2022-070115"},{"key":"483_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","volume":"47","author":"S de Sanjose","year":"2018","unstructured":"de Sanjose, S., Brotons, M. & Pavon, M. A. The natural history of human papillomavirus infection. Best Pract. Res. Clin. Obstet. Gynaecol. 47, 2\u201313 (2018).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"483_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/1743-422X-8-269","volume":"8","author":"R Faridi","year":"2011","unstructured":"Faridi, R., Zahra, A., Khan, K. & Idrees, M. Oncogenic potential of human papillomavirus (HPV) and its relation with cervical cancer. Virol. J. 8, 269 (2011).","journal-title":"Virol. J."},{"issue":"Suppl 5","key":"483_CR5","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","volume":"30","author":"D Forman","year":"2012","unstructured":"Forman, D. et al. Global burden of human papillomavirus and related diseases. Vaccine 30 (Suppl 5), F12\u201323 (2012).","journal-title":"Vaccine"},{"key":"483_CR6","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.ygyno.2010.01.024","volume":"117","author":"M Stanley","year":"2010","unstructured":"Stanley, M. Pathology and epidemiology of HPV infection in females. Gynecol. Oncol. 117, S5\u201310 (2010).","journal-title":"Gynecol. Oncol."},{"key":"483_CR7","doi-asserted-by":"publisher","first-page":"103675","DOI":"10.1016\/j.critrevonc.2022.103675","volume":"174","author":"R Bhattacharjee","year":"2022","unstructured":"Bhattacharjee, R. et al. Mechanistic role of HPV-associated early proteins in cervical cancer: molecular pathways and targeted therapeutic strategies. Crit. Rev. Oncol. Hematol. 174, 103675 (2022).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"483_CR8","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM de Vos","year":"2022","unstructured":"de Vos, W. M., Tilg, H., Van Hul, M. & Cani, P. D. Gut Microbiome and health: mechanistic insights. Gut 71, 1020\u20131032 (2022).","journal-title":"Gut"},{"key":"483_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajog.2018.12.011","volume":"221","author":"N Brusselaers","year":"2019","unstructured":"Brusselaers, N., Shrestha, S., van de Wijgert, J. & Verstraelen, H. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am. J. Obstet. Gynecol. 221, 9\u201318 (2019). e18.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"483_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/1471-0528.15854","volume":"127","author":"J Norenhag","year":"2020","unstructured":"Norenhag, J. et al. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG 127, 171\u2013180 (2020).","journal-title":"BJOG"},{"key":"483_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1021\/acsinfecdis.0c00839","volume":"7","author":"F Borella","year":"2021","unstructured":"Borella, F. et al. Gut microbiota and gynecological cancers: A summary of pathogenetic mechanisms and future directions. ACS Infect. Dis. 7, 987\u20131009 (2021).","journal-title":"ACS Infect. Dis."},{"key":"483_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13568-019-0763-z","volume":"9","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Altered diversity and composition of the gut Microbiome in patients with cervical cancer. AMB Express. 9, 40 (2019).","journal-title":"AMB Express"},{"key":"483_CR13","doi-asserted-by":"crossref","unstructured":"Kang, G. U. et al. Dynamics of fecal microbiota with and without invasive cervical Cancer and its application in early diagnosis. Cancers (Basel) 12, (2020).","DOI":"10.3390\/cancers12123800"},{"issue":"Suppl 1","key":"483_CR14","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/jac\/dkp433","volume":"65","author":"PA Hunter","year":"2010","unstructured":"Hunter, P. A. et al. Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies. J. Antimicrob. Chemother. 65 (Suppl 1), i3\u201317 (2010).","journal-title":"J. Antimicrob. Chemother."},{"key":"483_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apt.13302","volume":"42","author":"E Montassier","year":"2015","unstructured":"Montassier, E. et al. Chemotherapy-driven dysbiosis in the intestinal Microbiome. Aliment. Pharmacol. Ther. 42, 515\u2013528 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"483_CR16","doi-asserted-by":"publisher","first-page":"8125","DOI":"10.2147\/CMAR.S265205","volume":"12","author":"J Tong","year":"2020","unstructured":"Tong, J. et al. Changes of intestinal microbiota in ovarian Cancer patients treated with surgery and chemotherapy. Cancer Manag Res. 12, 8125\u20138135 (2020).","journal-title":"Cancer Manag Res."},{"key":"483_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(86)92972-7","volume":"1","author":"MB Katan","year":"1986","unstructured":"Katan, M. B. & Apolipoprotein, E. isoforms, serum cholesterol, and cancer. Lancet 1, 507\u2013508 (1986).","journal-title":"Lancet"},{"key":"483_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith, G. D. & Ebrahim, S. Mendelian randomization\u2019: can genetic epidemiology contribute to Understanding environmental determinants of disease? Int. J. Epidemiol. 32, 1\u201322 (2003).","journal-title":"Int. J. Epidemiol."},{"key":"483_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","volume":"53","author":"A Kurilshikov","year":"2021","unstructured":"Kurilshikov, A. et al. Large-scale association analyses identify host factors influencing human gut Microbiome composition. Nat. Genet. 53, 156\u2013165 (2021).","journal-title":"Nat. Genet."},{"key":"483_CR20","doi-asserted-by":"publisher","first-page":"14357","DOI":"10.1038\/ncomms14357","volume":"8","author":"K Suhre","year":"2017","unstructured":"Suhre, K. et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat. Commun. 8, 14357 (2017).","journal-title":"Nat. Commun."},{"key":"483_CR21","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","volume":"50","author":"W Zhou","year":"2018","unstructured":"Zhou, W. et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat. Genet. 50, 1335\u20131341 (2018).","journal-title":"Nat. Genet."},{"key":"483_CR22","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/s41588-021-00954-4","volume":"53","author":"L Jiang","year":"2021","unstructured":"Jiang, L., Zheng, Z., Fang, H. & Yang, J. A generalized linear mixed model association tool for biobank-scale data. Nat. Genet. 53, 1616\u20131621 (2021).","journal-title":"Nat. Genet."},{"key":"483_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess, S. et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open. Res. 4, 186 (2019).","journal-title":"Wellcome Open. Res."},{"key":"483_CR24","doi-asserted-by":"crossref","unstructured":"Ji, D., Chen, W. Z., Zhang, L., Zhang, Z. H. & Chen, L. J. Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study. J Neuroinflammation 21, 2, (2024).","DOI":"10.1186\/s12974-023-02999-0"},{"key":"483_CR25","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/ije\/dyx028","volume":"45","author":"FP Hartwig","year":"2016","unstructured":"Hartwig, F. P., Davies, N. M., Hemani, G. & Davey Smith, G. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int. J. Epidemiol. 45, 1717\u20131726 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"483_CR26","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","volume":"26","author":"S Burgess","year":"2017","unstructured":"Burgess, S., Small, D. S. & Thompson, S. G. A review of instrumental variable estimators for Mendelian randomization. Stat. Methods Med. Res. 26, 2333\u20132355 (2017).","journal-title":"Stat. Methods Med. Res."},{"key":"483_CR27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658\u2013665 (2013).","journal-title":"Genet. Epidemiol."},{"key":"483_CR28","doi-asserted-by":"crossref","unstructured":"Liu, M. et al. Analysing the causal relationship between potentially protective and risk factors and cutaneous melanoma: A Mendelian randomization study. J. Eur. Acad. Dermatol. Venereol., (2023).","DOI":"10.1111\/jdv.19484"},{"key":"483_CR29","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect Estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512\u2013525 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"483_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent Estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304\u2013314 (2016).","journal-title":"Genet. Epidemiol."},{"key":"483_CR31","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig, F. P., Davey Smith, G. & Bowden, J. Robust inference in summary data Mendelian randomization via the zero modal Pleiotropy assumption. Int. J. Epidemiol. 46, 1985\u20131998 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"483_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0006-3223(98)00043-2","volume":"44","author":"F Curtin","year":"1998","unstructured":"Curtin, F. & Schulz, P. Multiple correlations and Bonferroni\u2019s correction. Biol. Psychiatry. 44, 775\u2013777 (1998).","journal-title":"Biol. Psychiatry"},{"key":"483_CR33","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"MF Greco","year":"2015","unstructured":"Greco, M. F., Minelli, C., Sheehan, N. A. & Thompson, J. R. Detecting Pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat. Med. 34, 2926\u20132940 (2015).","journal-title":"Stat. Med."},{"key":"483_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess, S. & Thompson, S. G. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur. J. Epidemiol. 32, 377\u2013389 (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"483_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal Pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693\u2013698 (2018).","journal-title":"Nat. Genet."},{"key":"483_CR36","doi-asserted-by":"crossref","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 7, (2018).","DOI":"10.7554\/eLife.34408"},{"key":"483_CR37","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.jtho.2019.04.007","volume":"14","author":"Y Jin","year":"2019","unstructured":"Jin, Y. et al. The diversity of gut Microbiome is associated with favorable responses to Anti-Programmed death 1 immunotherapy in Chinese patients with NSCLC. J. Thorac. Oncol. 14, 1378\u20131389 (2019).","journal-title":"J. Thorac. Oncol."},{"key":"483_CR38","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nri2850","volume":"10","author":"N Cerf-Bensussan","year":"2010","unstructured":"Cerf-Bensussan, N. & Gaboriau-Routhiau, V. The immune system and the gut microbiota: friends or foes? Nat. Rev. Immunol. 10, 735\u2013744 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"483_CR39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","volume":"25","author":"BA Helmink","year":"2019","unstructured":"Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V. & Wargo, J. A. The microbiome, cancer, and cancer therapy. Nat. Med. 25, 377\u2013388 (2019).","journal-title":"Nat. Med."},{"key":"483_CR40","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1111\/jcmm.14289","volume":"23","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy. J. Cell. Mol. Med. 23, 3747\u20133756 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"483_CR41","doi-asserted-by":"publisher","first-page":"124428","DOI":"10.1016\/j.ijbiomac.2023.124428","volume":"240","author":"S Aziz","year":"2023","unstructured":"Aziz, S. et al. Structure-based identification of potential substrate antagonists for isethionate sulfite-lyase enzyme of Bilophila Wadsworthia: towards novel therapeutic intervention to curb gut-associated illness. Int. J. Biol. Macromol. 240, 124428 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"483_CR42","doi-asserted-by":"crossref","unstructured":"Waqas, M. et al. Multi-Fold computational analysis to discover novel putative inhibitors of isethionate Sulfite-Lyase (Isla) from Bilophila Wadsworthia: combating colorectal Cancer and inflammatory bowel diseases. Cancers (Basel) 15, (2023).","DOI":"10.3390\/cancers15030901"},{"key":"483_CR43","doi-asserted-by":"crossref","unstructured":"Martin, R. et al. Faecalibacterium: a bacterial genus with promising human health applications. FEMS Microbiol. Rev. 47, (2023).","DOI":"10.1093\/femsre\/fuad039"},{"key":"483_CR44","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1021\/acsinfecdis.2c00305","volume":"8","author":"Y Che","year":"2022","unstructured":"Che, Y. et al. Correlation of the gut microbiota and antitumor immune responses induced by a human papillomavirus therapeutic vaccine. ACS Infect. Dis. 8, 2494\u20132504 (2022).","journal-title":"ACS Infect. Dis."},{"key":"483_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1880220","volume":"13","author":"Q Meng","year":"2021","unstructured":"Meng, Q. et al. The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with Circulating lipid metabolites. Gut Microbes. 13, 1\u201327 (2021).","journal-title":"Gut Microbes"},{"key":"483_CR46","doi-asserted-by":"publisher","first-page":"2078620","DOI":"10.1080\/19490976.2022.2078620","volume":"14","author":"A Lavelle","year":"2022","unstructured":"Lavelle, A. et al. Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer. Gut Microbes. 14, 2078620 (2022).","journal-title":"Gut Microbes"},{"key":"483_CR47","doi-asserted-by":"publisher","first-page":"e0081623","DOI":"10.1128\/msphere.00816-23","volume":"9","author":"D Liu","year":"2024","unstructured":"Liu, D. et al. Anaerostipes Hadrus, a butyrate-producing bacterium capable of metabolizing 5-fluorouracil. mSphere 9, e0081623 (2024).","journal-title":"mSphere"},{"key":"483_CR48","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M Vetizou","year":"2015","unstructured":"Vetizou, M. et al. Anticancer immunotherapy by CTLA-4 Blockade relies on the gut microbiota. Science 350, 1079\u20131084 (2015).","journal-title":"Science"},{"key":"483_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy, B. et al. Gut Microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91\u201397 (2018).","journal-title":"Science"},{"key":"483_CR50","doi-asserted-by":"publisher","first-page":"1170326","DOI":"10.3389\/fcimb.2023.1170326","volume":"13","author":"X Lu","year":"2023","unstructured":"Lu, X. et al. Structure of gut microbiota and characteristics of fecal metabolites in patients with lung cancer. Front. Cell. Infect. Microbiol. 13, 1170326 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"483_CR51","doi-asserted-by":"publisher","first-page":"2473522","DOI":"10.1080\/19490976.2025.2473522","volume":"17","author":"K Jiang","year":"2025","unstructured":"Jiang, K. et al. Interbacterial warfare in the human Gut: insights from bacteroidales\u2019 perspective. Gut Microbes. 17, 2473522 (2025).","journal-title":"Gut Microbes"},{"key":"483_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrmicro2298","volume":"8","author":"O Tenaillon","year":"2010","unstructured":"Tenaillon, O., Skurnik, D., Picard, B. & Denamur, E. The population genetics of commensal Escherichia coli. Nat. Rev. Microbiol. 8, 207\u2013217 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"483_CR53","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41467-017-00901-0","volume":"8","author":"C Chen","year":"2017","unstructured":"Chen, C. et al. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat. Commun. 8, 875 (2017).","journal-title":"Nat. Commun."},{"key":"483_CR54","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","volume":"16","author":"MG Rooks","year":"2016","unstructured":"Rooks, M. G. & Garrett, W. S. Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16, 341\u2013352 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"483_CR55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.semcancer.2022.03.005","volume":"86","author":"M Kyrgiou","year":"2022","unstructured":"Kyrgiou, M. & Moscicki, A. B. Vaginal Microbiome and cervical cancer. Semin Cancer Biol. 86, 189\u2013198 (2022).","journal-title":"Semin Cancer Biol."},{"issue":"e1621","key":"483_CR56","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.cell.2024.02.022","volume":"187","author":"D Jia","year":"2024","unstructured":"Jia, D. et al. Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer. Cell 187 (e1621), 1651\u20131665 (2024).","journal-title":"Cell"},{"key":"483_CR57","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s42003-021-01741-x","volume":"4","author":"TT Sims","year":"2021","unstructured":"Sims, T. T. et al. Gut Microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Commun. Biol. 4, 237 (2021).","journal-title":"Commun. Biol."},{"key":"483_CR58","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4161\/gmic.28684","volume":"5","author":"JS Bajaj","year":"2014","unstructured":"Bajaj, J. S. The role of microbiota in hepatic encephalopathy. Gut Microbes. 5, 397\u2013403 (2014).","journal-title":"Gut Microbes"},{"key":"483_CR59","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Nino","year":"2022","unstructured":"Galeano Nino, J. L. et al. Effect of the intratumoral microbiota on Spatial and cellular heterogeneity in cancer. Nature 611, 810\u2013817 (2022).","journal-title":"Nature"},{"key":"483_CR60","doi-asserted-by":"publisher","first-page":"e2405331","DOI":"10.1002\/adma.202405331","volume":"36","author":"F Peng","year":"2024","unstructured":"Peng, F. et al. Intratumoral microbiota as a target for advanced Cancer therapeutics. Adv. Mater. 36, e2405331 (2024).","journal-title":"Adv. Mater."},{"key":"483_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","volume":"8","author":"L Yang","year":"2023","unstructured":"Yang, L., Li, A., Wang, Y. & Zhang, Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal. Transduct. Target. Ther. 8, 35 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"e2319","key":"483_CR62","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","volume":"187","author":"TW Battaglia","year":"2024","unstructured":"Battaglia, T. W. et al. A pan-cancer analysis of the Microbiome in metastatic cancer. Cell 187 (e2319), 2324\u20132335 (2024).","journal-title":"Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00483-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T06:02:46Z","timestamp":1746252166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00483-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00483-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Our analysis utilized publicly accessible genome-wide association study (GWAS) summary statistics, without the collection of new data or the need for additional ethical approval.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"15490"}}